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ABSTRACT 
IBD (inflammatory bowel disease) is a pandemic chronic disease of the 
gastrointestinal tract inducing Ulcerative colitis (UC) and Crhon disease (CD). The 
inflammation of colon especially associated with the growing risk of developing colon 
cancer. To extend the research on IBD, chemical mice models are investigated on easy 
way to induce colitis in rodent. Dextran sulfate salt (DSS) 7 days, 3% in drinking water 
induce IBD on mice. One of the problem of DSS is that it requires a purification step of 
mRNA by LiCl. This step induce this mRNA harvest rate quantitatively and qualitatively.  
In this study, we synthesized Pullulan Sulfate and Cyclodextrin Sulfate as 
alternative colitis inducers in mice. The specificity of sulfated polysaccharides in colon 
versus small intestine has been confirmed by common gastrointestinal method (pro 
inflammatory cytokines causes degradation of the epithelium, and the presence of blood 
in stool.) 
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1 INTRODUCTION  
1.1 A brief introduction of inflammatory bowel disease 
Inflammatory bowel disease is a group of diseases occurring in the bowel 
system. Main one named Crohn’s disease (CD, occurring in all digestive track) and 
ulcerative colitis (UC, mainly colon) are the basic types of inflammatory bowel disease 
(1). 
With a high morbidity and high mortality in developing area such as North Africa, 
China and India, IBD remains to be one of the most severe diseases around the 
world.(2) Patients suffer reduce intestine-stomach colic, long-term diarrhea, body weight 
losing and blood stools physically. Most of them also meet psychosocial problem like 
anxiety and depression on mental. This is especially a severe social problem which will 
lead patients to worry about their behavior and increase their anxiety disorder (1-3). 
CD is an inflammatory bowel disease is a multifactorial disease (infection, 
heredity, cellular immunity) which mechanisms still keeps unknown.  
IBD in Asia— during the past two decades, IBD reports and prevalence has a 
striking rising. According a study 2007, as a model of developed country, Japan has the 
prevalence of UC risen from 78 reports per million individuals to 636 reports per million 
individuals. Another studies on Singapore IBD prevalence, UC prevalence has 
increased from 60 reports per million individuals to 86 reports per million individuals, 
and the prevalence of CD has risen from 13 reports per million individuals to 72 reports 
per million individuals. As in Korea, there has also been a substantial rise in the 
prevalence of UC—from 76 reports per million individuals in 1997 to 309 reports per 
million individuals in 2007 (6,8). 
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Reasons that might responsible for the rising prevalence of IBD in Asia likely 
including industrialization of societies, deterioration of environmental factors 
(Westernization of lifestyle included),  changes in diet (with the increasing economy, 
Asians eat more meat than mid 20th century), a huge advancement sanitation, and 
possibly, increasing using of antibiotics in medical treatment. In almost countries in 
Asia, antibiotics can now be extremely easily obtained from any pharmacy facility, in 
some areas, antibiotics are even not prescription drug. The assumption that antibiotic 
use earlier in childhood may augment the risk of IBD is hold by several case-control 
studies conducted in the West (9). 
 In Asia UC is over number CD, relatively much as it was in the other areas like 
Europe and north America (6.7) But, preliminary evidence also suggests that CD would 
overtake UC in developing countries over time (6.7.8). 
IBD in America—An increase in the number of IBD patients is also continually 
shown, reflecting a rising need for more research to find a cure. In United states, about 
1.6 million Americans are currently reported have IBD, An organization named Crohn’s 
and Colitis foundation of Americans (CCFA) is monitoring the IBD spreading and 
situation of IBD patients. According to their recent reports, a growth of Approximate 
200,000 since the last time CCFA reported IBD population (in 2011). Every year, Mor6e 
than 70,000 new cases of IBD are diagnosed in the United States. What is worse? A 
significant part of them are children—thenre may be as many as 80,000 children in the 
United States with IBD in total. 
Due to highly developed medical condition and clinic technology, circumstance of 
IBD carriers are getting better and better. Based on the publications of CCFA, 
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biochemists have identified over 160 genes related to IBD. Investigation of these genes 
will revolutionize our understanding of Crohn’s disease and ulcerative colitis mechanism 
and form the basis for investigating new drugs and equipment (10). 
1.1.1 Different types of IBDs 
CD and UC are the most common IBD. CD is more likely to be reported in 
western world, while UC is more common in Asia (11).  
Table 1: Overall difference between UC and CD 
Difference UC CD 
Inflammatory 
disorder 
Inflammation will be continuous 
throughout affected areas 
Inflammation might periodically occur in 
patches 
Position Large intestine is basically the 
specifically affected site 
Inflammation may attack anywhere 
along the gastrointestinal tract 
 
 
exterior 
Colon wall is thinner and shows 
continuous inflammation 
Mucus lining of large intestine may 
have ulcers, but they do not extend 
beyond the inner lining 
Large intestine wall may be thickened 
and may have a rocky appearance 
Ulcers along the digestive track are 
deep and may extend into all layers of 
the bowel wall 
Pain Pain occurs in the lower left part of the 
abdomen 
Pain is commonly taken place in the 
lower right abdomen 
Bleeding Bleeding from the rectum during bowel 
movements 
Bleeding from the rectum during bowel 
movements is not common 
 
1.1.1.1 Crohn’s disease 
CD—it is named after Dr. Burrill B. Crohn that is first physician who described the 
disease in 1932. When talking about inflammatory bowel diseases, it is fundamental to 
realize that CD is not the same thing as UC, another type of IBD. These two IBDs share 
quite similar symptoms, but differ from areas affected in the gastrointestinal tract (GI 
tract). 
The end of the small bowel (the ileum) and the beginning of the colon is mostly 
affected by Crohn’s, while it is able to affect any part of the gastrointestinal (GI) tract, 
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thus, from the esophagus to the anal opening. UC is just limited to the colon part, also 
called the large intestine, from cecum to rectum (14). 
 
Figure 1: Crohn's disease, http://gastro.seoimportant.com/gi-diseases-and-conditions/crohns-disease 
 
CD is also able to attack the whole thickness of the bowel wall, while UC only 
involves the innermost lining of the large intestine. Finally, in CD, the inflammation of 
the intestine can “skip”—leaving functional areas between patches of diseased 
intestine. In UC this does not occur. 
The symptoms patients might experience: 
Common—skin rash, slow growth, acute episodes, arthritis, depression, mouth 
ulcer, anal fissure, and bodyweight loss. 
Pain—severe pain in the rectum, abdomen, low abdomen or joints. 
Body—vomit, nausea and fever (13.15). 
1.1.1.2 Ulcerative colitis 
Ulcerative colitis—is a colon chronic disease, also known as a basic type of IBD, which 
is  the lining of the large intestine becomes inflamed and develops extremely small out 
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sores, or ulcers, that generate pyaemia and mucous. The integration of inflammation 
and ulceration is able to cause gastrointestinal pain and periodic emptying of the colon. 
UC is the result of an abnormal response by your body's immune system. Normally, the 
cells and proteins that make up the immune system protect you from infection. In people 
with IBD, however, the immune system mistakes food, bacteria, and other materials in 
the intestine for foreign or invading substances. When this happens, the body sends 
white blood cells into the lining of the intestines, where they produce chronic 
inflammation and ulcerations (16). 
 
Figure 2: ulcerative colitis, http://www.ulcerativecolitis.net/colitis 
 
It’s significant to tell the difference between ulcerative colitis and Crohn's disease. UC 
affects only the large intestine, on the other hand CD can affect any part of the 
Gastrointestinal (GI) Tract, from oral cavity to anus. Furthermore, while Crohn’s disease 
is able to attack any layers of the bowel system, ulcerative colitis only affects the inner 
of the colon. 
The symptoms patients might experience: 
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Common—scarring within the bile ducts or weight loss. 
Pain—intermittent abdominal pain, joints or rectum pain. 
Abdominal—tenderness or cramping. 
Gastrointestinal—diarrhea, constipation, urgent need of defecation, colon tissue 
bloating, blood in stool, bowels empty inability, or leaking of stool (16.17). 
 
 
Table 2: different symptoms of ulcerative colitis (UC) and Crohn’s disease (CD 
Symptoms of Ulcerative Colitis Symptoms of Crohn's Disease 
Anemia caused by severe bleeding Abdominal pain, cramping or 
swelling 
Abdominal pain or discomfort Persistent or recurrent diarrhea 
Urgent bowel movements Gastrointestinal bleeding 
Loss of appetite Stomach ulcers 
Rectal bleeding Malabsorption 
Bloody diarrhea Weight loss 
Malabsorption  Joint pain 
Dehydration Vomiting 
Weight loss Anemia 
Fatigue Fever 
Joint pain   
Fever   
 
1.1.2 Research model. 
Among the advantages to use mouse model, the most important is their striking 
similarity to humans in anatomy, physiology, and genetics.  Over 95% of the mouse 
genome is similar to our own, making mouse genetic research particularly applicable to 
human disease. 
Practically, mice are a cost-effective and efficient tool to speed research and the 
development of drug therapies. Mice are small and have a short generation time 
required to perform accelerated preliminary research experiments. 
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In addition, our ability to directly manipulate the mouse genome provides an 
incredibly powerful tool to model specific diseases for which the causative gene is 
known. For example, Ulcerative .colitis can be induced by knocking down IL-10. 
1.1.3 Common methods used to induce IBD mice model 
NO2
SO3H
NO2
NO2
 
Figure 3: Semi-developed formula of 2, 4, 6-trinitro benzene sulfonic acid 
2, 4, 6-trinitro benzene sulfonic acid (TNBS), dextran sulfate sodium (DSS) and 
oxazolone are mostly research used inflammatory bowel disease inducers on mouse 
model. 
2, 4, 6-trinitro benzene sulfonic acid (TNBS) model—The reason of TNBS 
induced colitis is because of susceptible strains of animals, for example rats, mice and 
rabbit. It will be delivered by instillation of the complex of TNBS and ethanol. Why 
ethanol is necessary is because it can break the mucosal barrier, so that TNBS can 
associated to large intestine autologous or microbial proteins having an interaction with 
the host immune system, which is supposed to be immunogenic. 
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As we know, CD 4+ T cells have already performed as a central role in TNBS 
induced colitis, this kind of colitis is usually used in studying T helper cell-dependent on 
the strain and independent modification of the concentrations of TNBS administered is 
necessary. Especially for generating colonic colitis. 
Oxazolone colitis—oxazolone is another well-known reagents that research 
people widely used to induce inflammatory bowel disease on rodent animal like mouse. 
Mice skin will be painted with 2.5 percent oxazolone dissolved in 100 percent ethanol 
for first 2 days, then painted with 2.5 percent oxazolone dissolved in 50 percent ethanol 
in the following a week. Mice will be characterized by their daily body weight change 
rate, diarrhea, length of colon and bloody stools. In oxazolone colitis mice model, only 
distal colon and particularly mucosal layers will be attacked by the inflammatory disease. 
Just like what has been observed in human ulcerative colitis, histology test has shown 
that, Th2 cytokines, for example IL-6, TNF-alpha and P53 has dramatically increased 
compare to normal tissue. According to this discovery, this model will be a good choice 
for ulcerative colitis model. 
N
O
Ph
O
OEt
 
Figure 4: Semi-developed formula of oxazolone 
 
Dextran sulfate sodium
to TNBs and oxazolone. Because it is much more easy to use
drinking water. No need to inject reagent into mice anal, or make an organic solution 
then smear it onto mice skin. Mice will 
water, and over a duration of 7 days, mice will have a severe inflammatory bowel 
disease. 
Figure 5: Semi-developed formula of 
The degree of substitution is 2. 
induced will be characterized by daily body weight change ratio or bloody diarrhea. 
Through the exactly reason of DSS is still keep unknown. There are 2 possible 
hypotheses is extensively accepted. 
DSS may be directly toxic to gut epithelial cells of the colon crypts, which will 
affects the quantity of the mucosal barrier. The other assumption is that 
quantitative reverse-transcription polymerase chain reaction (qRT
Dextran sulfate sodium is also used to induce chronic inflammatory bowel 
disease. Mice will be treated with 1 percent DSS water solution in drinking water for the 
first 5 days, then just water is offered to mice for another 5 days. And this circle is 
 colitis—in recent research, DSS is more used compared 
—directly dissolved into 
be treated with 3 percent DSS into drinking 
dextran sulfate sodium. 
  
C2 and C4 is sulfated. The acute colitis DSS 
 
-PCR). 
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DSS will inhibit 
 
repeated for 135 days. A very severe IBD is induced, which can be characterized by the 
mice daily body weight change, bloody diarrhea and length of colon. 
will be helpful to detect the severity of IBD. Especially, 45 days is slight inflammation, 90 
days is more serious while 90 days tissue is deadly, the whole colon is inflammatory, 
and the villus crypt is destroyed.
1.1.4 Pullulan 
Pullulan also named as
which is consisted with 3 glucose subunit named maltotriose. The so called moltotriose 
is make up with three glucose, which is bonded with 
maltotrioses are connected of 3 glucoses, which is connected with
bonds. it has a high similarity to Dextran.
 
Figure 6: Semi-developed formula of 
Histology methods 
 
α-1,4- ;α-1,6-glucan, is unique linear polysac
α-1,4 glycosidic bond
α
 
pullulan 
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charide, 
s. while the 
-1,4 glycosidic 
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Figure 7: Semi-developed formula of beta-cyclodextrin. 
Cyclodextrin is a family of polysaccharides that made up of several sugar 
moleculars bound in a ring. Beta-cyclodextrin is made of 7 glucose, which are 
connected with α-1, 4 glucosidic bond. This ring polysaccharide is generated by 
enzymatic conversion. They are often used in food, drug, chemical industry and 
pharmacy.  
Beta-cyclodextrin is consisted with 7 members in a ring. Starch and cyclodextrin 
glycosyltransferase are involved in the synthesie of cyclodextrin. 
 
2     EXPERIMENT 
In this section we described, our methods including synthesis of pullulan sulfate 
(PS) and Cyclodextrin sulfate (CS), animal experiment, surgical procedures, western 
blot, immunofluorescence, immunohistochemistry, histology, gravimetric method, 
infrared and NMR. 
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2.1 Organic chemistry experiment 
Pullulan sulfate and Cyclodextrin sulfate are synthesized, chlorosulfonic acid is 
used as sulfate agent. 
1H NMR and 13C NMR spectrums of pullulan sulfate are obtained with bruker 
600M instrument. 
Infrared spectrums of pullulan and pullulan sulfate are acquired by perkin elmer. 
2.1.1 Synthesis of polysaccharide sulfate 
Our idea to use pullulan sulfate and cyclodextrin as alternative to DSS is 
innovative as there is no sulfated pullulan or cyclodextran available on the market. 
Synthesis of PS and CS are achieved by pyridine- SO3 complex. 
 
Figure 8: synthesis reaction. Sulfonic acid is used to react with pyridine, pyridine-sulfate complex is 
generated, which will act as sulfate agent in the secondary step. 
Materials.—Pullulan was purchased from Tokyo Chemical Industry CO., LTD, 
(MW=2*105g/mol). Beta-Cyclodextrin was obtained from ACROS ORGANIC. 
(MW=1134.98). 
Agents.—all the agents used were of analytical grade. The formamide is 
obtained from ACROS ORGANIC. 99% for molecular biology.  
Preparation of the pyridine – -SO3 complex –40 ml pyridine was cooled in -20 ℃  
for 30 min. Then the pyridine with 2-neck flask was submerged into 1: 3 ratio salt ice 
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mixture. Nitrogen was blowing into the flask as protection for 10 min, then the flask was 
isolated from air with rubber flask caps. 16 ml Chlorosulfonic acid was added to the 
flask drop by drop in the fuming cupboard in case of Chlorosulfonic acid smoke was 
made (8ml Chlorosulfonic acid is added drop by drop in order to get a low sulfate 
degree compound, named PS I. while the higher sulfate degree compound obtained by 
adding double equilibrium of Chlorosulfonic is named PS II. CS II is at high degree of 
substitution. ). During adding the Chlorosulfonic acid, stirring was turn to medium level 
to break the pyridine –SO3 complex (solid) for a better reaction efficiency. A constant 
stirring is applied. The complex was put in the ice-salt mixture for next step. 
Synthesis—20ml of water free formamide was added into the flask for 
homogeneous reaction mixture. When all the pyridine –SO3 complex solid was 
dissolved, 2g of pullulan or cyclodextrin was weight and slowly added into the flask with 
the stirring on. A balloon of nitrogen was connected to the isolated reaction system to 
block oxygen and water from air and balance pressure. Set the heater to 85 ℃ (65, 80, 
85, 90 degree were used to obtain different degree of substitution).The reaction 
temperature was monitored. The sulfonation reaction took 4 h (continuous heating and 
stirring). 
Purification—100 ml ultrapure water was frozen in -80 ℃  then break to pieces. 
Then all the mixture was decanted into 1: 1 ultrapure water ice mixture. The mixture 
was stirred for 30 min to make sure all the mixture was cool down and dissolved. Then 
the solution was poured to 400 ml methyl alcohol for precipitation. After that, it was 
separated by centrifuge (5000 rpm for 10 min). This step was repeated 3 times, then the 
precipitate was redissolved by water and transfer to salt form by adding 10ml 5 M NaOH 
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solution. The salt solution was dialysed against water for 1 days (Water was changed 
every 6 h). Then sample was dialysed against ultrapure water for 3 day with constant 
stirring to get rid of ion and small impurities. Sample was precipitated with methyl 
alcohol again, then dissolved with water (in order to increase yield, water volume 30 
mL). Liquid nitrogen was used to quick freeze the whole flask. Then the flask was 
connected with lypholizer. Powder sample was obtained after 10 h. Dry sample was 
stored against air. 
2.1.2 13C NMR spectrum 
13C NMR spectrums were obtained by a 400M nuclear magnetic resonance 
spectrometer (bruker analytics) applying the Pulse Fourier Transform procedure. 
Deuterium (99.9 atom % D, alorich) oxide was used as solvent for 13C NMR. And 
deuterium dimethylsulfoxide (99.9 atom % D, alorich) was used as 1H NMR solvent. 
Factors: program zg. NS: 2048. DS: 4.  
2.1.3 Infrared spectrum 
Infrared spectrum was obtained by a  Fourier transform infrared spectroscopy 
(Nicolet iS10 from Thermo Scientific). Water free samples were mixed with potassium 
bromide. The spectrometer worked in the wave range from 4000 to 650 cm-1 in room 
temperature. The reference measurement was performed with a pure potassium 
bromide. Spectrometer’s Fourier self deconvolution function finished Final evaluation. 
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2.2 Biological experiment 
PS I, PS II and CS was given to mice in drinking water (3%). DSS, Pullulan are 
used as reference groups (3%). Respectively for colitis inducer, mice body weight was 
measured daily. 
2.2.1 Animal experiment 
All mice were grouped by 5 mice per cage at our animal facility Georgia State 
University, under controlled conditions of light (12:12 hour dark/light cycle), 5% humidity 
and 25˚C. All animal experiments were approved by the Institutional Animal Care and 
Use Committee of Georgia State University (Atlanta, GA), and in accordance with the 
guide for the Care and Use of Laboratory Animals by U.S. Public Health Service. 
Wild type mice were from Deltagen (San Mateo, CA). 25 mice were evenly 
divided to 5 group: Pullulan group, Pullulan sulfate I group, Pullulan sulfate II group, 
DSS group, cyclodextrin group and cyclodextrin sulfate group. The concentration was 
fixed at 3% in drinking water.  
Mice were sacrificed after 1 weeks. Large intestine length was recorded. Livers, 
small intestines, colons, spleens, hearts, lungs were collected and put in -80 ℃. 
2.2.2 PCR 
2.2.2.1 TRIZOL RNA Isolation 
Homogenization– tissue were homogenized in 2 ml of TRIZOL reagent per 100 
mg of tissue using a glass-Teflon or power homogenizer (OMNI international LH96-
Automatic homogenizer workstation). The sample volume should not exceed 10% of the 
volume of TRIZOL Reagent used for the homogenization. 
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Phase separation rinse—monolayer was cold with ice PBS for 5min. Lyse cells 
was directly put into a clean experiment plate, then 1 ml of TRIZOL Reagent was added 
to per 3.5 cm diameter dish and mixed with cell scraper. 
Sample was past to lysate several time through a micro pipette. Then the cell 
was homogenized through a vortex. Based on the area size of the dish used (96 holes), 
TRIZOL 10µL reagent was put into plate then completely mixed by the micro pipette. 
Otherwise, not enough amount of trizol reagent will lead to a contamination of DNA. 
RNA precipitation—the RNA was precipitated from liquid phase through the 
mixture of cell and isopropyl ethanol. In addition, 0.45ml of isopropyl ethanol is added 
into per ml of TRIZOL reagent, mix well. Then used as initial homogenization. 
Samples was incubated in the incubator 25°C for 10 to 15 min (depend on the 
sample amount), then centrifuge at 11000 x g for 10 min at 4°C for pellet RNA. 
RNA wash—after the centrifuge, supernatant was discarded completely, 
precipitate was collected, washed with gradient alcohol. Every ml of TRIZOL reagent 
was added more than 1ml of 75% alcohol. Vortex was used to mix these RNA 
precipitate and TRIZOL together. Then centrifuge again at 7000 x g for at least 5min, 
4°C. Above washing steps might have to be repeat according to the purity of the RNA 
precipitate. 
Spectrophotometric analysis—the RNA was diluted with DEPC-treated water at 
1:40 ratio. 260nm and 280nm is used to detect sample concentration and purity. Once 
the result of A260/A280 is larger than 1.6, then the convention that 1 OD at 260nm 
equals 40µg /ml RNA. 
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2.2.3 mRNA purification. 
Due to a strong inhibition effect of polysaccharide sulfate to both polymerase and 
reverse transcriptase, the mRNA cannot be used to make standard cDNA. So mRNA 
purification is necessary. According to the method published in 2013 by Dr. Viennois 
(33), LiCl can be used to precipitate polysaccharide sulfate molecular. the RNA were 
precipitated twice by 0.1 volume of 8 M LiCl, followed by a precipitation step in 0.1 
volume of 3 M sodium acetate (pH 5.2) and 2 volumes of 100% ethanol. The RNA were 
then centrifuged, pellets were washed with 100 µL of 70% ethanol and RNAs were 
finally dissolved in 20-50 µl of RNase-free water. 
2.2.3.1 Standard cDNA synthesis 
Maxima First Strand cDNA Synthesis Kit for RT-qPCR from thermo scientific is 
used to make standard cDNA. In the beginning, an ice box is prepared. Then a sterile 
and RNAse-free tube is put on the ice. The reaction reagents were added into this order: 
5x reaction mixture 4µL, maxima enzyme 2µL, template RNA 3µg, and nuclease-free 
water 20 µL. the tube was mixed on vortex for 10 min. then centrifuged at 5000 rpm 
4degree 10min. Precipitate was disgarded. And the supernate was incubated for 10min 
at 25 ℃. And then incubated at 50 ℃ for 15min. 
Due to the primer sequence is GC rich sequence, which is with a large amount of 
secondary structure RNA template. The reaction temperature is increased to 65 ℃. The 
terminate reaction temperature is set as 85 ℃ for 5min. The product is stored in -20 
freezer. 
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2.2.4 Cell biology and histology 
Paraffin embedding, OCT embedding, sectioning, H&E staining, 
immunofluorescence, immunohistochemistry were finished. 
2.2.4.1 Paraffin embedding and sectioning.  
Paraffin embedding—organs were dehydrated by being immersed into 50% 
ethanol alcohol for 90 min, 70% ethanol alcohol for 90 min, 85% ethanol alcohol for 90 
min, 95% ethanol alcohol for 90 min, 100% ethanol alcohol for 60 min twice.  
Embedding—Organs were washed with xylene ethanol alcohol 1:1 mixture for 60 
min, then washed with xylene for 60 min twice. After that, they were permeated by 
xylene and paraffin 1:1 mixture for 90 min at 62 ℃, paraffin alone for 90 min at 62 ℃. 
Histology Cassettes was used to form organs with hot flowing paraffin. Then the organs 
included in paraffin solidified on the cold station for 5 h, then cassettes were put into -
20 ℃ for 2 days. 
Sectioning—Shandon™ Finesse™ 325 Manual Microtome (from thermo 
scientific) is used to section paraffin embedding organs. The organs buried in the 
paraffin were cut to 5 micrometer thick slices, then they were collected by ultraclear 
microscope slides (from denville) 5 pieces of organs in a row. Then the slides were soak 
in 42 ℃ water bath for 5 min to extend folded tissue. The slides were dried by a hotplate 
at 35 ℃ for 20 min. 
2.2.4.2 Hematoxylin and eosin (H&E) staining. 
Slides were washed with xylene for 5 min 3 times to remove paraffin. Then they 
were soaked into 100% ethanol alcohol for 10 min, 95% ethanol alcohol for 10 min, 70% 
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ethanol alcohol for 5 min. After that, slides were rinsed in distilled water for 10 min. 
Slides were stained in hematoxylin for 6min with holder. Then they were washed with 
flowing tap water to wipe off attached hematoxylin then immersed in distilled water for 3 
min. After washing, they were Decolorize in acidic alcohol just 1 tap or 1 second and 
rinsed in distilled water 3 min again. Then slides were immersed into Eosin for 10 
seconds. After that, slides were dehydrated by 70% ethanol alcohol washing for 10 min, 
95% ethanol alcohol washing for 10 min, 100% ethanol alcohol washing for 5 min twice. 
Sides were soaked into xylene 70% ethanol alcohol 1:1 solution for 1 min, and washed 
by xylene for 1min as following. Cytoseal was used as mounting media to protect 
covered tissues. Finally, stained slides were observed under a microscope (M130 from 
denville). 
2.2.4.3 Immunofluorescence  
OCT slides were pre-observed and rinsed with ultrapure water for 10 min to 
eliminate OCT. Then the tissues were completely oxidized by hydrogen peroxide for 30 
min and washed with 1x PBS with calcium and magnesium for 10 min again. Then 
slides were incubated with citrate buffer A (45 ml 0.1 M citrate buffer mixture with 205 
ml 0.1 M sodium citrate buffer) for 10 min and cooled down. Washed again with 1x PBS 
with calcium and magnesium for 10 min. Then the slides were blocked with blocking 
buffer for 45 min at room temperature. After that, diluted primary antibody buffer was 
incubated with slides for an hour at room temperature. Next, the slides were washed 
again with 1x PBS for 3 min 3 times. Incubated with proper secondary antibody for 1 
hour at room temperature as follows. Slides were covered with DAPI solution then 
protected by microscope cover slides. 
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Table 3: buffers used for IF 
buffer recipe 
1x PBS 
mix the following reagents into 500mL ultrapure water  
80.00g of NaCl 
2.00g of KCl 
14.40g of Na2HPO4 
2.40g of KH2PO4 
Adjust pH to 7.40 
Adjust volume to 1L with additional distilled H2O. 
Then sterilize by autoclaving. 
blocking buffer 
To prepare 10 ml, add 0.5 ml BSA from the same species as the 
secondary antibody to 9 ml 1X PBS) and vortex for 5 min. add 30 µl 
Triton™ X-100 while stirring. 
1° Ab 
IL6, TNF alpha, P53 antibodies were used. 
IL6 1µL to 1mL 
TNF alpha 5µL to 1 mL 
P53 2µL to 1 mL 
Dilute antibody with blocking buffer at proper dilution ratio 
2°Ab Goat anti-rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488 
conjugate. Dilution ration: 1:500 in  
citrate buffer A 45 mL 0.1M citrate acid buffer mix with 205 mL 0.1M sodium citrate acid buffer. 
DAPI DAPI concentration was 0.5µg/mL 1xPBS. Stored in 4 degree. 
2.2.4.4 Immunohistochemistry 
Slides were firstly washed by xylene for 10 min, then washed by 100% ethanol 
alcohol washing for 5 min, 95% ethanol alcohol washing for 5 min, 70% ethanol alcohol 
washing for 5 min twice. Then the tissues on the slides were fixed by formalin for 10 min, 
then hydrogen peroxide was used to block the peroxidase. After washing with 1x PBS, 
the slides were incubated with citrate buffer B for antigen retrieval. Pressure cooker 
bottom was filled with distilled water, slides with citrate buffer was set in the container, 
then cooked in high pressure for 10 min cooled for 1 hour on bench. The slides were 
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completely cooled down, then washed with 1x TBS for 3 min 3 times. Then an immedge 
pen was used to circle the tissue on the slides. 
Blocked with blocking buffer at room temperature for 45 min as follows. After 
blocking, those slides were incubated with primary antibody for 1 hour at room 
temperature. Then the rest primary antibody buffer was washed with 1x TBS for 3 min 3 
times. Slides was incubated with secondary antibody for 1 hour at room temperature. 
Diluted DAB reaction buffer was dropped on the tissue circled for 5 min. Then DAB 
buffer was washed by 1x PBS with calcium and magnesium. Slides were stained with 
hematoxylin for 6 min and washed with 1x PBS. Finally, the tissues were protected with 
cytoseal and covered. 
Table 4: buffers used in IHC 
buffer recipe 
1x PBS 
mix the following reagents into 500mL ultrapure water  
80.00g of NaCl 
2.00g of KCl 
14.40g of Na2HPO4 
2.40g of KH2PO4 
Adjust pH to 7.40 
Adjust volume to 1L with additional distilled H2O. 
Then sterilize by autoclaving. 
1x TBS 
Dissolve the following reagents into 500mL tap water 
6.05 g Tris 
8.76 g NaCl  
Adjust pH to 7.5 with 1 M HCl  
make volume up to 1 L with H2O. TBS is stable at 4°C for 3 mo. 
blocking buffer  
To prepare 10 ml, add 0.5 ml BSA from the same species as the 
secondary antibody to 9 ml 1X PBS) and vortex for 5 min. add 30 µl 
Triton™ X-100 while stirring. 
1° Ab 
IL6, TNF alpha, P53 antibodies were used. 
IL6 1µL to 1mL 
TNF alpha 5µL to 1 mL 
P53 2µL to 1 mL 
Dilute antibody with blocking buffer at proper dilution ratio 
2°Ab ABC kit from VECTOR LAB. 
citrate buffer B 
2.94g sodium citrate in 950mL dH2O 
Adjusted pH to 6.0, add 0.5mL Tween-20, add dH20 up to 1L.  
Mixed well 
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DAPI DAPI concentration was 0.5µg/mL 1xPBS. Stored in 4 degree. 
 
3     RESULTS 
3.1 Synthesis analysis 
3.1.1 13C NMR 
 
Fig.9 show the 13C NMR spectra of P and PS. Since PS is obtained from P and 
pyridine –SO3 complex, there was not influence of the molar mass on the position of the 
peaks. In other words, sulfonation was the only factor that is able to differ 13C NMRs 
between P and PS. Due to a good solubility of P into water, D2O was chosen as the 
solution of 13C NMR spectra. 
 
 
Figure 9: Pullulan (P) and pullulan sulfate (PS) 13C NMR spectrum confirmed sulfate group location. 
Concentration:0.030g/0.5ml D2O. Range from 55ppm to 105ppm. Green line—PS, Red line—P 
As a classic linear alpha glucan, pullulan has the representative feature of ring 
carbohydrate. Thus the glucose ring is shown on the spectra. It could be seen that the 
C-1 glucose ring carbon absorbed at 97.93, C-2 at 71.71, C-3 at 73.43, C-4 at 69.47, C-
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5 at 70.33 and C-6 at 66.45 ppm (22-25). It has a high possibility that by branching at C-
4, down field shifted resonances was not detected. Thus introduction of sulfate groups 
on pullulan might have a preference on taking place at the C-3. The ring carbons 
reactivity was in the order C-3>C-2>C-4. The substitution of a hydrogen atom by a 
sulfate group led to a down field shift of roughly 5 ppm of the appropriate C resonance 
and to a high field shift at the neighbouring C atoms, (26, 27) caused by magnetic 
anisotropy of the sulfate neighbouring groups. Since the local magnetic field was 
averaged over all segment movements and since these movements were slow, the line 
width was approximately 10 times larger than those of low-molecular materials. Due to 
the installation of the heavy sulfate group this effect was stronger for the sulfates than 
for the pure saccharides. 
For the pulluan, no visible high field effect was observed at the C-6 and C-5 
positions. The C-3 signal appeared at 77.58 ppm. Two additional smaller C-3 signals 
appeared at 82.88 and 79.57 ppm, describing the sulfates at C-2 and C-4. Besides the 
high field C-2 resonance at 71.87 ppm there was also a down field shifted signal of the 
sulfated C-2 at 75.51 ppm. The signals at 70.85 and 70.27 ppm arose from the C-5. 
This double split could be the result from a high field shift due to the sulfonation at the 
C-4. The down field shifted C-4 signal was negligible with respect to the resonance of 
the other signals. The 69.25 ppm peak was probably a high-field shifted resonance of 
the sulfated C-4 which occurred when a sulfate group was attached at the C-3.  
3.1.2 FTIR spectrum 
There were two obviously characteristic absorption bands showed on TFIR 
spectroscopy. On one hand, the peak at 1250 cm-1 indicated a sulfur atom and oxygen 
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atom double band asymmetrical vibration. On the other hand, the one at 850 cm-1 
referred to a symmetrical C-O-S vibration associated to a C-O-SO3 group. As for 
pullulan spectrum, the 920 -1band described alpha-(1.6) linkages. While alpha-(1. 4) 
linkages were observed at 970 cm-1. Ring deformations and scaffold vibrations were 
showed at 710, 650 cm-1. The absorptions at 850 and 765 cm_1 showed that pullulan 
sulfate had a 4C1 chair conformation. 
 
Figure 10: Sulfate group identification  by IR spectrum of Pulluan and PS.Orange line—PS, pink line—
Pullulan 
 
As for pullulan sulfate, the 815 cm-1 absorption band discribed a symmetrical C-O-S 
vibration, with C-O-C bending vibration at 755 cm-1. Just like it is showed in Pullulan 
spectrum, the ring deformation and scaffold vibrations were observed at 700 cm-1. 
There was no influence of the polymer molar mass and only a marginal influence on the 
degree of substitution. With increasing DS the intensity of the OH absorption band 
decreased slightly. A similar result was found by Miyaji (34). 
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3.2 Degree of substitution 
Degree of substitution (DS) is detected gravimetrically. Accurate 1.0000g sample 
was weight, and dissolved with 10mL HCl (10%). Then the solution was precipitated 
with BaCl2 (25%). The precipitate was obtained by filtration, then washed with DI water 
for an hour to make the solid ions free. Muffle oven was used to heat the solid to ash 
(800℃ for 3h). The degree of substitution was calculated with following formula: 
 
 
Table 5: Measurement of the degree of substitution is detected gravimetrically. 
temperature/℃ 65 80 85 85 90 
degree of 
substitution 1.31 2.02 0.71 2.09 Carbonization 
acid used per gram 
polysaccharide/mL 8 8 4 8 8 
ash weight/g 1.1419 1.4526 0.754 1.4775 NA 
color white powder yellow solid white powder yellow solid dark solid 
 
3.3 Anatomy 
Mice were treated with regular food and 3 percent PS II in drinking water for a 
span over 7 days, during the week, daily bodyweight change is recorded. Then those 
mice were sacrificed. Shorter colon and bloody stools were found. 
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Figure 11: PS II, CS and DSS induced colitis, confirmed by bodyweight change measurement. DSS—dextran 
sulfate sodium; PS II—pullulan sulfate II (DS=2.1); PS I—pullulan sulfate I (DS=0.7); P—pullulan; C—cyclodextrin; CS—
cyclodextrin sulfate. 
 
As shown in Fig. 11. PS II and DSS treated mice is keep losing weight over a 
week. On the other hand, PS I and Pullulan group mice body weight are not changing, 
even gain weight. Consider of those mice were 8 weeks old, and pullulan is a diet food, 
the body weight change is normal compared to the PS II and DSS group. This is a solid 
evidence that PS II induced IBD on those mice just ass DSS performed. 
 
Figure 12: PS II induced colitis is confirmed by blood stools and diarrhea. 
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5 mice were put in this box for 20 min. It is white background. And bloody stools 
is everywhere. 
Bloody stools is the classic feature of ulcerative colitis. Mice which is treated with 
dextran sulfate sodium will have bloody stools on day 5. In this pullulan sulfate II group, 
bloody stools was found on day 4. This support our hypothesis that pullulan sulfate has 
a similar effect on inducing IBD on mice model, which is ulcerative colitis not Crohn’s 
disease. 
 
Figure 13: Colon length as colitis indicator compared to healthy colon. 
7 centimeter long. No bleeding, no swelling is found. No erosion is found either. 
Compare to normal colon from a healthy mouse. Inflammation colon is shorter. 
Because mice body immune system is keeping killing inflammation cells. The 
inflammation part is swelling and bleeding obviously. All this also supported our 
ulcerative colitis model assumption. PS II just have same effect on inducing IBD 
compared to DSS. 
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Figure 14: Pullulan sulfate II (PS II) induced colitis.  
Its 4 centimeter long. Bleeding, swelling, and shorter. The whole colon is with 
erosion. 
 
Figure 15: the specificity for colon is confirmed by the small intestine length. 
Its 30 centimeter long. No bleeding, no swelling is found. No erosion is found 
either. The whole small intestine is healthy, not inflammation feature is found. 
On the other hand, unlike the colon, small intestine is free of the PS II affection. It 
keeps just as seem as the healthy small intestine. In this case, it is 30 centimeter long. 
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No bleeding, swelling and erosion is found. 
 
Figure 16: Normal length of small intestine of pullulan sulfate II group confirming the specificity of 
PSII for colon. 
Its 30 centimeter long. No bleeding, no swelling is found. No erosion is found 
either. The whole small intestine is healthy, not inflammation feature is found. 
 
 
Figure 17: PS II, CS and DSS show shorter colon, which is a solid evidence of colitis. DSS—dextran 
sulfate sodium; PS II—pullulan sulfate II (DS=2.1); PS I—pullulan sulfate I (DS=0.7); P—pullulan; C—cyclodextrin; 
CS—cyclodextrin sulfate. 
 
 
Another typical feature of 
inflammation, mice immune system is clearing those sick cells, mice have a shorter 
colon. 
Figure 18: Length of small intestine for polysaccharides tested. Inflammation is no
small intestine. DSS—dextran sulfate sodium; PS II
P—pullulan; C—cyclodextrin; CS—cyclodextrin sulfate.
3.4 Histology 
Figure 19: colitis is confirmed by histology (H&E staining.). 
DSS—dextran sulfate sodium, PS I
A 
C 
inflammation bowel disease is shorter colon. Due to the 
—pullulan sulfate II (DS=2.1); PS I—pullulan sulfate I (DS=0.7); 
 
 
DSS PSI and pullulan is used as control. 
—low sulfate rate pullulan sulfate. P—
B 
D 
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t present in the 
 
 
pullulan. 
 DSS, PS II, PS I and Pullulan were dissvoled with water at 3 percent 
concentration. And then feed to mice over a span of 7days. Then mice was sacrificed, 
the colon was buried with paraffin and H&E staining. A: DSS colon, the base of crypt is 
totally destroyed by the inflammation.  B: PS II colon, the base of crypt is totally 
destroyed by the inflammation
inflammation was found. D: PS I colon, tissue remain integra
found. 
Histological appearance of the mice colonic mucosa after 
Mucosal injury was produced and characterized by necrosis of epithelium, focal 
ulcerative of the mucosa and diffused infiltration of n
Figure 20: the specificity for colon is confirmed by histology
used as control. DSS—dextran sulfate sodium, PS I
DSS, PS II, PS I and Pullulan were dissvoled with water at 3 percent 
concentration. And then feed to mice over a span
the small intestine was buried with paraffin and H&E staining. A: DSS colon, the base of 
crypt remains integrated, villus structure is clear and no inflammation was found.  B: PS 
C 
A 
. C: Pullulan colon, tissue remain integrated. No 
ted. No inflammation was 
DSS 
eutrophil and lymphocyte (20x).
 (H&E staining). DSS PSI and pullulan is 
—low sulfate rate pullulan sulfate. P—pullulan. 
 
 of 7days. Then mice was sacrificed, 
B 
D 
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administration. 
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II small intestine, the base of crypt remains integrated, villus structure is clear and no 
inflammation was found. C: Pullulan small intestine, tissue remain integrated. No 
inflammation was found. D: PS I small intestine, tissue remain integrated. No 
inflammation was found. 
3.5 PCR 
 
Figure 21:  Colonic cytokine measurement (TNF alpha) using PS II induced colitis (fold expression 
change of mRNA). P—pullulan, PS 1—low sulfate rate pullulan.PS II—high sulfate rate pullulan. DSS—dextran 
sulfate sodium 
 
TNF a is chosen as primer. PS II and DSS have an incredible increment compare 
to Pullulan and PS I. thus inflammation is detected in PS II and DSS treated tissue. 
Tumor necrosis factor (TNF alpha) is a well-known adipokine, which is used as 
cell signaling protein. It is related to systemic inflammation and is able to make up an 
acute reaction. TNF alpha can be generated by activated macrophages, CD4+ 
lymphoctyes, NK cells and eosinophils. 
P 
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The basic role of TNF alpha is to regulate body immune system. It can induce 
fever, cachexia, inflammation even has potential to inhibit tumorigenesis. It also respond 
to sepsis via IL 1 and IL 6 producing cells. 
It is made use of a variety of human diseases, especially inflammatory bowel 
disease (29). Fig 5 shows different expression of TNF alpha in colon and small intestine 
tissue. In colon tissue, it has a significant expression on PS group and DSS group. And 
no expression on P and PSI group. On the other hand, it has no obvious distinction 
between PS, PS I, DSS and P groups. 
In this case, In this case, PS II and DSS colon shows an absolutely higher TNF 
alpha level compare to healthy tissue, thus pullulan and PS I group, which indicates the 
inflammation. 
 
Figure 22: Colonic cytokine measurement (IL-10) using PS II induced colitis (fold expression change 
of mRNA).  P—pullulan, PS 1—low sulfate rate pullulan .PS II—high sulfate rate pullulan. DSS—dextran sulfate 
sodium. 
 
 
P 
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Interleukin-10, in short, IL-10 is a well-known anti-inflammation cytokine. It is 
encoded IL-10 gene.  
IL-10 protein is a homodimer, which is consisted with 178 amino acid. 
In normal cells, IL-10 protein is inhibited, only very few amount IL-10 protein can 
be detected. While in inflammation cells, as an anti-inflammation cytokine, it is highly 
expressed to fix body inflammation. In other words, it will be obviously increased in 
inflammation cells (31). 
In this case, PS II is just as effective as DSS inducing IBD. Even stronger—PS II 
has a 41 relatively fold change compare to DSS 22 fold change.  
In this case, PS II and DSS colon shows an absolutely higher IL-10 level 
compare to healthy tissue, thus pullulan and PS I group, which indicates the late severe 
inflammation. 
 
Figure 23: PS II induced colitis is confirmed by the fold change of cox 2 of colon. P—pullulan,  
PS 1—low sulfate rate pullulan sulfate.PS II—high sulfate rate pullulan sulfate. DSS—dextran sulfate sodium 
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Cyclooxygenase-2, in short Cox-2, is a primarily responsible for inflammation. In 
1991, it is discovered that COX exists in 2 form, Cox-1 and Cox-2. Cox-2 is relative to 
inflammation, but on the other hand, it is not for gastrointestinal integrity or platelet 
aggregation, which means Cox-2 inhibiter will work as an anti-inflammation, but 
minimize the risk of bleeding and gastrointestinal toxicity. Now it is developed and 
people are already make benefits from it. 
In our research, Cox-2 is chosen as another inflammation bio marker. In PS II 
and DSS group, it shows a dramatic increment compare to P and PS I group, which 
also proved our hypothesis that PS II works just same as DSS. PS II is able to induce 
severe inflammation on colon tissue. 
3.6 IHC 
Immunohistochemistry is a very important and useful method to detect 
inflammation on the digestive track. 
IL-6 and TNF alpha are chosen as the detection bio- maker protein. 
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Figure 24: PS II induced colitis is confirmed by IHC, IL-6 is used as primary antibody. A: pullulan 
sulfate I (PS II) I colon. B: dextran sulfate sodium (DSS) colon. C: pullulan sulfate I (PS I) colon. D: pullulan (P) colon. 
 
As shown in Fig 25, A and B is PS II and DSS tissue. The whole tissue is 
anabrotic, base and base crypt is totally melt, cells is everywhere, and not organized. 
Especially PS II, brown is DAB color of IL-6, while purple is hematoxylin counterstain. 
The expression of the IL6 protein is significantly increasing in the colonic tissue attesting 
of severe colitis. On the other hand. Hematoxylin is used as counterstain, there is no IL-
6 expression on C and D, but the purple color of hematoxylin. Which is a clear evidence 
that PS II is able to induce severe inflammation on colon. And cooperation A and B. we 
can tell that the whole tissue is broken in A, on picture B, there is some part is still 
remain organized.  
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Figure 25: IHC picture of IL-6 on small intestine tissue. A: pullulan sulfate II (PS I) I small intestine, B: 
dextran sulfate sodium (DSS) small intestine, C: Pulluan (P) small intestine, D: pullulan sulfate I (PS I) small intestine. 
 
As shown in Fig 26.there is no broken tissue is found. All the cells are 
organized by its tissue, and no IL-6 expression is found on this picture. Only the 
healthy tissue is shown by hematoxylin. 
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Figure 26: IHC picture of TNF alpha on colon tissue. A: pullulan sulfate II (PS II) colon, B: dextran sulfate 
sodium (DSS) colon, C: Pulluan (P) colon, D: pullulan (PS I) colon. 
 
 
Figure 27: IHC picture of TNF alpha on small intestine tissue. A: pullulan sulfate II (PS II) small intestine, 
B: dextran sulfate sodium (DSS) small intestine, C: Pulluan (P) small intestine, D: pullulan sulfate I (PS I) small 
intestine. 
 
As they are shown in Fig 27 and 28, there is a huge increment of TNF alpha 
expression on PS II and DSS colon tissue, while the expression is lower on Pullulan and 
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PS I group. Which means that healthy tissue does not have a large TNF alpha 
expression, while the inflammation tissue has a lot. 
The A and B of Fig 28 are less organized, which means the tissue is 
histologically inflammation.  
 
In Fig. 28, IL-6 was used as 1° Ab to detect the inflammation on CS colon. There 
is obviously IL-6 expression (brown color) on CS colon tissue, which indicates a strong 
inflammation on the CS treated mice colon. 
3.7 Histologic score 
Histological scoring was decided by three factors. 
Figure 28: CS induced colitis is confirmed by IHC. CS colon (left) and normal colon (right). 
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Figure 29: polysaccharide sulfates induced colitis is confirmed by histology scores. 
 
Table 6 inflammation scoring is based on severity of inflammation, crypt damage and ulceration. 
 
As it is shown above, Pullulan and Cyclodextrin do not induce inflammation. Low 
degree of substitution pullulan barely induce colitis. PS II induced a stronger 
inflammation on mice compare to DSS and CS. 
scores 
severity of inflammation crypt damage ulceration 
0 no inflammation was found intact crypt no ulcer 
1 
granulocyte numbers was increasing 
in lamina 
1/3 base lost small spot of ulcer 
2 
inflammatory cells were found in the 
submucosa 
2/3 base lost  3 or 4 foci of ulcer 
3 none whole base lost extensive ulcer 
4 none 
erosion on 
epithelial surface 
none 
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3.8 Immunofluorescence 
Base on the paraffin sections, immunofluorescence is finished with IL-6, TNF 
alpha and P53 used as primary antibody. 
Recently, a high relative link between chronic inflammatory and cancer is found. 
Which is supported by the negative regulation of NF-κB, a major inflammation regulator. 
And P 53 is what it is relative to. P 53 is a major tumor suppressor. 
However, for reasons, once the P53 is active, NF-κB activity, inflammation and 
immune responses will be decreased. Therefore, P53 has anti-cancer function. 
 
 
Figure 30 : PS II induced colits is cinfirmed by IF colon data, P53 is used as 1° Ab. P 53 is used as 1° 
Ab. A: P 53 on PS II colon. B: DAPI on same tissue of A. C: P53 on DSS colon. D: DAPI on same tissue of C. E: P53 
on PS I colon. F: DAPI on same tissue of E. G: P53 on Pullulan colon. H: DAPI on same tissue of G.  
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Figure 31: the specificity for colon is confirmed by IF small intestine data, P53 is used as 1° Ab. A: P53 on 
PS II small intestine. B: DAPI on same tissue of A. C: P53 on DSS small intestine. D: DAPI on same tissue of C. E: 
P53 on PS I small intestine. F: DAPI on same tissue of E. G: P53 on Pullulan small intestine. H: DAPI on same 
tissue of G.  
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As shown in Fig 33, P 53 is used as primary antibody. To observe the P 53 
(green) of Pullulan and PS I group, a longer exposure time is used compare DAPI. On 
the other hand, DSS and PS II group even take a shorter exposure time to observe the 
P 53 (green). Which means that DSS and PS II have a strong fluorescence signal 
compare to PS I and Pullulan group. Thus DSS and PS II have a high P53 level. Which 
indicates that there is strong inflammation in PS II and DSS treated mice colon, while no 
inflammation is found in Pullulan and PS I treated mice. 
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Figure 32: PS II induced colitis is confirmed by IF, IL-6 is used as 1° Ab. A: IL-6 on PS II colon. B: DAPI on 
same tissue of A. C: IL-6 on DSS colon. D: DAPI on same tissue of C. E: IL-6 on PS I colon. F: DAPI on same tissue 
of E. G: IL-6 on Pullulan colon. H: DAPI on same tissue of G. 
 
As shown in Fig34, all P53 group (green) used 400ms to expose, while DAPI 
(blue) just use 50µs. which still indicates that no difference of P53 expression of PS II, 
DSS, PS I and Pullulan. This proved the inflammation selectivity on colon. 
As shown in Fig34, Il-6 is used as primary antibody. To observe the IL-6 (green) 
of Pullulan and PS I group, a longer exposure time is used compared to DAPI. On the 
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Figure 33: IF small intestine data, IL-6 is used as 1° Ab. A: IL-6 on PS II small intestine. B: DAPI on 
same section slide of A. C: IL-6 on DSS small intestine. D: DAPI on same section slide of C. E: IL-6 on PS I small 
intestine. F: DAPI on same section slide of E. G: IL-6 on Pullulan small intestine. H: DAPI on same section slide of 
G.  
 
other hand, DSS and PS II group even take a shorter exposure time to observe the IL-6 
(green). But still, we didn’t observe any green (IL-6). This indicates that DSS and PS II 
have a strong fluorescence signal compare to PS I and Pullulan group. Thus DSS and 
PS II have a high IL-6 level.  
 
However, as shown in Fig 35. For all IL-6 group (green), a much longer exposure 
time is used, 400ms. And all the DAPI group, which is blue, a shorter exposure time (50 
µs) is applied. However, we are not able to confirm IL-6 in PS II small intestine. This 
46 
result means, in small intestine, IL-6 is not expressed. Thus PS II has an inflammation 
selectivity on colon. 
Figure 34: the specificity of PS II induced colitis for colon is confirmed by IF liver picture.
IL-6 is used as 1° Ab. A: IL-6 on PS II liver. Exposure time 400ms. B: DAPI on same tissue of A. 
exposure time 50µs. C: IL-6 on DSS liver. Exposure time 400ms. D: DAPI on same tissue of C. exposure 
time 50µs. E: IL-6 on PS I liver. Exposure time 400ms. F: DAPI on same tissue of E. exposure time 50µs. 
G: IL-6 on Pullulan liver. Exposure time 400ms. H: DAPI on same tissue of G. exposure time 50µs. 
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We also tried IL-6 on liver tissue. All IL-6 picture share a long exposure time of 
400ms, while the DAPI picture share a short exposure time of 50µs. Thus the IL-6 stays 
inhibited in liver, due to the positive relation between IL-6 and inflammation, no 
inflammation is found in liver, which proved the specificity of PS II induced colitis for 
colon. 
To detect the inflammation on CS colon tissue, IL-6 is used as 1° Ab, which 
shows IL-6 (green) (left). DAPI is used as counterstain, which shows DAPI (blue, on the 
right). The IL-6 is obviously increasing. 
 
 
 
 
 
 
 
 
Figure 35: CS induced colitis is confirmed by IF, IL-6 is used as 1° Ab. 
Figure 36: the specificity of CS induced colitis for colon is confirmed by IF pictures of CS small 
intestine, IL-6 is used as 1° Ab. 
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However, no IL-6 signal (green) is found at same exposure time: 40µs. only DAPI 
(blue) can be seen. Which indicates that no IL-6 expressed in small intestine after 7 
days CS treatment on mice. 
 
4 CONCLUSIONS 
A series of experiments were finished including primary organic compound 
synthesis, animal experiments and advanced biochemistry analysis methods. A 
high degree of substitution Pullulan (PS II), a low degree of substitution Pullulan (PS 
I) and cyclodextrin sulfate were successfully synthesized with pyridine sulfate 
complex, then preliminarily purified. The sulfate group was verified and the sulfate 
rate of substitution was detected by gravimetric system. 
Polysaccharide sulfates were fed to mice in 3% drinking water over a period of 7 
days, the body weight change is recorded every day. PS II and CS showed a better 
time effect on inducing IBD over a span of 6days compared to DSS model which 
need a week. Furthermore, the anatomy also proved the inflammation by the 
appearance of shorter colon, bleeding in colon, swelling colon and bloody stool. CS 
and PS II kept mice losing weight just as DSS performed. 
H&E staining showed relatively similar level of inflammation to the DSS for the colon 
cross section. On the other hand, no inflammation was found in small intestine and 
liver cross section. 
Pullulan sulfate successfully induced inflammatory markers as shown by the qPCR 
data: IL10, Cox-2, TNF alpha.  
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Immunofluorescence indicated that PS II and CS both were able to increase the P 
53 and IL-6 in mice colon. The specificity on colon other than small intestine also 
proved the inflammation is UC not CD. 
The selective location—colon, also indicated that the inflammation is UC not CD. 
On the other hand, no inflammation occurred in small intestine and liver, which is 
also proved by histology, immunofluorescence and immunohistochemistry. The 
hypothesis that pullulan sulfate and cyclodextrin sulfate show at least same ability 
on inducing inflammation on colon was supported by all these evidence. 
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APPENDICES  
(A) 1H NMR 
 
Figure 37:1H NMR spectrum of pullulan 
 
Figure 38: 1H NMR spectrum of pullulan sulfate 
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(B)  
Table 6, qPCR primer sequence 
Primer Sequence (Sense, Antisense) Product Size, bp 
Cycle 
Number 
Annealing 
T°C 
Mouse 5’- CCGGAGAGGAGACTTCACAG -3’ 
421 30 62 
IL-6 5’- GGAAATTGGGGTAGGAAGGA -3’ 
    
Mouse 
TNF-a 
5’-  
TACTGAACTTCGGGGTGATTGGTCC 
-3’ 
290 24 65 5’-  
CAGCCTTGTCCCTTGAAGAGAACC -
3’ 
  
Mouse 
GAPDH 
5’- ACCACAGTCCATGCCATCAC -3’ 450 15 65 5’- CACCACCCTGTTGCTGTAGCC -3’ 
Mouse 5’- TTCAACTCTGTCTCCTTCCT-3’ 
554 32 56 
P53 5’- CAGCCCTGTCGTCTCTCCAG-3’ 
 
 
